We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$341M
AUM Growth
-$852M
Cap. Flow
-$875M
Cap. Flow %
-256.9%
Top 10 Hldgs %
61.35%
Holding
204
New
1
Increased
1
Reduced
75
Closed
122

Top Buys

Rank Stock Value
1
AMU
ETRACS Alerian MLP Index ETN
AMU
+$562K
2
PRCP
Perceptron Inc
PRCP
+$91.4K

Top Sells

Rank Stock Value
1
ACWV icon
iShares MSCI Global Min Vol Factor ETF
ACWV
+$76.3M
2
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
+$63.1M
3
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$47.3M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$33.2M
5
IYR icon
iShares US Real Estate ETF
IYR
+$32.9M

Sector Composition

Rank Sector Weight
1 Financials 6.67%
2 Communication Services 2.66%
3 Healthcare 1.09%
4 Technology 0.9%
5 Consumer Discretionary 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
76
Qualcomm
QCOM
$181B
$222K 0.07%
3,461
-35,123
-91% -$2.13M
UNP icon
77
Union Pacific
UNP
$179B
$216K 0.06%
1,610
-21,846
-93% -$2.63M
CVS icon
78
CVS Health
CVS
$137B
$212K 0.06%
2,923
-21,197
-88% -$1.54M
HBAN icon
79
Huntington Bancshares
HBAN
$37B
$166K 0.05%
11,425
– –
F icon
80
Ford
F
$56.7B
$137K 0.04%
11,000
-131
-1% -$1.61K
UBFO
81
DELISTED
United Security Bancshares
UBFO
$137K 0.04%
12,480
– –
PRCP
82
DELISTED
Perceptron Inc
PRCP
$99K 0.03%
+10,143
New +$91.4K
ABBV icon
83
AbbVie
ABBV
$450B
– –
-4,262
Closed -$379K
ACN icon
84
Accenture
ACN
$87.9B
– –
-2,204
Closed -$298K
ACWX icon
85
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
– –
-117,717
Closed -$5.69M
ADBE icon
86
Adobe
ADBE
$94.3B
– –
-2,554
Closed -$381K
AEP icon
87
American Electric Power
AEP
$71.9B
– –
-10,549
Closed -$741K
AGG icon
88
iShares Core US Aggregate Bond ETF
AGG
$139B
– –
-7,874
Closed -$863K
BA icon
89
Boeing
BA
$169B
– –
-1,105
Closed -$281K
BAC icon
90
Bank of America
BAC
$430B
– –
-16,481
Closed -$418K
BBH icon
91
VanEck Biotech ETF
BBH
$399M
– –
-15,903
Closed -$2.13M
BDX icon
92
Becton Dickinson
BDX
$43.6B
– –
-1,534
Closed -$293K
BIV icon
93
Vanguard Intermediate-Term Bond ETF
BIV
$29.1B
– –
-4,050
Closed -$343K
BMY icon
94
Bristol-Myers Squibb
BMY
$124B
– –
-15,340
Closed -$978K
BNDX icon
95
Vanguard Total International Bond ETF
BNDX
$82.2B
– –
-106,832
Closed -$5.83M
BOX icon
96
Box
BOX
$4.22B
– –
-34,822
Closed -$673K
BRK.A icon
97
Berkshire Hathaway Class A
BRK.A
$1.06T
– –
-11
Closed -$3.02M
CAH icon
98
Cardinal Health
CAH
$53.5B
– –
-4,223
Closed -$283K
CLX icon
99
Clorox
CLX
$11.6B
– –
-2,573
Closed -$339K
COST icon
100
Costco
COST
$417B
– –
-2,045
Closed -$336K
2 3
4
5 6

Similar funds

BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.51B AUM 39.24% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return

Aspiriant LLC's Q4 2017 Portfolio in Review

As of Q4 2017, Aspiriant LLC held 204 positions worth $341M, down 71% from $1.19B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Aspiriant LLC withdrew a net $875M in Q4 2017, closing 122 positions and reducing 75 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, up from 4.8% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Aspiriant LLC opened a new position in Perceptron Inc worth $99K.

  • Aspiriant LLC's largest Q4 2017 buy was Perceptron Inc: 10,143 shares worth $99K.
  • Aspiriant LLC added most to ETRACS Alerian MLP Index ETN in Q4 2017, an estimated $562K increase.
  • Aspiriant LLC's biggest Q4 2017 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $76.3M.
  • Aspiriant LLC fully exited iShares US Real Estate ETF in Q4 2017, selling an estimated $32.9M.
  • Aspiriant LLC's ten largest holdings make up 61% of its $341M portfolio in Q4 2017.
  • Aspiriant LLC opened 1 new position and closed 122 in Q4 2017.
  • Aspiriant LLC's portfolio value fell 71% quarter-over-quarter to $341M.

Based on Aspiriant LLC's 13F filing for Q4 2017, filed 31 Jan 2018.